FNY Investment Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $662K | Buy |
27,324
+10,414
| +62% | +$252K | 0.28% | 101 |
|
|
2025
Q1 | $428K | Buy |
16,910
+3,446
| +26% | +$87.2K | 0.26% | 86 |
|
|
2024
Q4 | $357K | Buy |
13,464
+7,075
| +111% | +$188K | 0.18% | 112 |
|
|
2024
Q3 | $184K | Sell |
6,389
-265
| -4% | -$7.63K | 0.09% | 173 |
|
|
2024
Q2 | $186K | Buy |
6,654
+4,654
| +233% | +$130K | 0.12% | 123 |
|
|
2024
Q1 | $55 | Buy |
2,000
+1,112
| +125% | +$31 | 0.03% | 246 |
|
|
2023
Q4 | $25K | Buy |
+888
| New | +$25K | 0.03% | 245 |
|
|
2023
Q3 | – | Sell |
-29,500
| Closed | -$1.08M | – | 685 |
|
|
2023
Q2 | $1.08M | Buy |
+29,500
| New | +$1.08M | 1.37% | 17 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 667 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 763 |
|
|
2022
Q2 | – | Sell |
-3,776
| Closed | -$195K | – | 812 |
|
|
2022
Q1 | $195K | Buy |
+3,776
| New | +$195K | 0.18% | 106 |
|
|
2021
Q3 | – | Sell |
-200
| Closed | -$7K | – | 818 |
|
|
2021
Q2 | $7K | Buy |
+200
| New | +$7K | ﹤0.01% | 571 |
|
|
2021
Q1 | – | Sell |
-13,975
| Closed | -$514K | – | 898 |
|
|
2020
Q4 | $514K | Buy |
+13,975
| New | +$514K | 0.14% | 132 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 546 |
|
|
2020
Q1 | – | Sell |
-211
| Closed | -$7K | – | 680 |
|
|
2019
Q4 | $7K | Buy |
+211
| New | +$7K | ﹤0.01% | 622 |
|